首页> 外文期刊>Journal of biomedical science. >Induction of nitric oxide synthase in RAW 264.7 macrophages by lipoteichoic acid from Staphylococcus aureus: involvement of protein kinase C- and nuclear factor-kB-dependent mechanisms.
【24h】

Induction of nitric oxide synthase in RAW 264.7 macrophages by lipoteichoic acid from Staphylococcus aureus: involvement of protein kinase C- and nuclear factor-kB-dependent mechanisms.

机译:来自金黄色葡萄球菌的脂磷壁酸诱导RAW 264.7巨噬细胞中的一氧化氮合酶:参与蛋白激酶C和核因子kB依赖性机制。

获取原文
获取原文并翻译 | 示例
           

摘要

This study investigates the signaling pathway involved in inducible nitric oxide synthase (iNOS) expression and nitric oxide (NO) release caused by Staphylococcus aureus lipoteichoic acid (LTA) in RAW 264.7 macrophages. A phosphatidylcholine-phospholipase C (PC-PLC) inhibitor (D-609) and a phosphatidylinositol-phospholipase C (PI-PLC) inhibitor (U-73122) attenuated LTA-induced iNOS expression and NO release. Two PKC inhibitors (Go 6976 and Ro 31-8220), an NF-kappaB inhibitor (pyrrolidine dithiocarbamate; PDTC), and long-term (24 h) 12-phorbol-13-myristate acetate (PMA) treatment each also inhibited LTA-induced iNOS expression and NO release. Treatment of cells with LTA caused an increase in PKC activity; this stimulatory effect was inhibited by D-609, U-73122, or Ro 31-8220. Stimulation of cells with LTA caused IkappaB-alpha phosphorylation and IkappaB-alpha degradation in the cytosol, and translocation of p65 and p50 NF-kappaB from the cytosol to the nucleus. Treatment of cells with LTA caused NF-kappaB activation by detecting the formation of NF-kappaB-specific DNA-protein complexes in the nucleus; this effect was inhibited by Go 6976, Ro 31-8220, long-term PMA treatment, PDTC, L-1-tosylamido-2-phenylethyl chloromethyl ketone (TPCK), and calpain inhibitor I. These results suggest that LTA might activate PC-PLC and PI-PLC to induce PKC activation, which in turn initiates NF-kappaB activation, and finally induces iNOS expression and NO release in RAW 264.7 macrophages.
机译:本研究调查了由RAW 264.7巨噬细胞中的金黄色葡萄球菌脂蛋白酸(LTA)引起的诱导型一氧化氮合酶(iNOS)表达和一氧化氮(NO)释放的信号通路。磷脂酰胆碱磷脂酶C(PC-PLC)抑制剂(D-609)和磷脂酰肌醇磷脂酶C(PI-PLC)抑制剂(U-73122)减弱了LTA诱导的iNOS表达和NO释放。两种PKC抑制剂(Go 6976和Ro 31-8220),一种NF-κB抑制剂(吡咯烷二硫代氨基甲酸酯; PDTC)和长期(24小时)12-phorbol-13-肉豆蔻酸酯乙酸酯(PMA)处理也均抑制LTA-诱导iNOS表达和NO释放。用LTA处理细胞会导致PKC活性增加;这种刺激作用被D-609,U-73122或Ro 31-8220抑制。用LTA刺激细胞会导致IkappaB-alpha磷酸化和IkappaB-alpha在细胞质中降解,并使p65和p50 NF-kappaB从细胞质中转移到细胞核。用LTA处理细胞可通过检测细胞核中NF-κB特异性DNA-蛋白质复合物的形成而引起NF-κB活化。 Go 6976,Ro 31-8220,长期PMA治疗,PDTC,L-1-甲苯磺酰基-2-苯基乙基氯甲基酮(TPCK)和钙蛋白酶抑制剂I抑制了该作用。这些结果表明LTA可能激活PC- PLC和PI-PLC诱导PKC活化,进而启动NF-κB活化,并最终诱导RAW 264.7巨噬细胞中iNOS表达和NO释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号